Bacterial enzyme systems and macromolecules

Bacterial enzyme systems and macromolecules represent the diverse array of molecular targets within prokaryotic cells that are exploited by antimicrobial therapy. These targets encompass critical cellular processes including cell wall biosynthesis, protein synthesis via the 30S and 50S ribosomal subunits, and nucleic acid metabolism involving enzymes like DNA gyrase and RNA polymerase (StatPearls, 2023; Merck Manual, 2024). Drugs such as beta-lactams, aminoglycosides, and fluoroquinolones interact with these specific components to disrupt bacterial growth or cause cell death (Microbiology Spectrum, 2018). Because these systems often differ significantly from their eukaryotic counterparts, they allow for selective toxicity against pathogens while minimizing harm to the host (Nature Reviews Microbiology, 2017). However, the rapid evolution of bacterial resistance mechanisms, such as target modification or enzymatic degradation, poses a significant challenge to the continued efficacy of drugs targeting these systems (WHO, 2023). This broad classification is often used in pharmacological databases to group various antibiotics that do not share a single specific protein target but rather act on essential bacterial machinery (ChEMBL, 2024).

Other names

Bacterial targetsProkaryotic enzymes and macromoleculesBacterial cell componentsAntimicrobial targets

Inhibition of cell wall synthesis, inhibition of protein synthesis, inhibition of DNA replication, and inhibition of RNA synthesis.